A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia
Clinical trial NCT00210717 · COMPLETED
Trial details
- NCT number
- NCT00210717
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Enrollment
- 748
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.